Greece-based industrial conglomerate MYTILINEOS is increasing its presence within the nation’s renewable vitality and vitality storage market.

MYTILINEOS is buying a portfolio of 20 photo voltaic vitality farms, with a complete capability of 1,48GW, from EGNATIA Group.

The photo voltaic vitality initiatives will probably be accomplished by the tip of 2023.

The two firms have additionally agreed on a deal during which MYTILINEOS will purchase some 21 battery vitality storage initiatives and 4 photo voltaic+vitality storage initiatives from EGNATIA Group.

Have you learn?
Mytilineos provides to photo voltaic portfolio in Australia
Italy’s Terna selects MYTILINEOS to ship 26MW of battery storage capability

The developments are a part of efforts by MYTILINEOS to play a key position in Greece’s vitality transition, in addition to to arrange itself for future enterprise fashions.

The bulletins come after MYTILINEOS contracted an influence buy settlement of 200MW from photo voltaic parks owned by EGNATIA GROUP for €33/MWh ($40/MWh) and for a interval of 10+5 years.  

This PPA is anticipated to take impact in 2023. 

The developments have expanded MYTILINEOS’ Greek portfolio of inexperienced vitality to 1.480MW at a mature licensing stage, 300MW on the stage of operation and development and 100MW ready for last funding resolution on the finish of 2021.

Abroad, the agency’s portfolio of photo voltaic vitality contains 400MW on the stage of development, 120MW to be accomplished with industrial operation due within the second quarter of 2021, 501MW is able to be constructed and four,000MW is at an preliminary licensing stage.

Sign up for our publication

Abroad, the agency additionally has a pipeline of 25 electrical energy storage initiatives and 200MW in a signed PPA with a 3rd celebration, at a mature licensing stage.

The submit Greece’s MYTILINEOS expands renewables and vitality storage portfolios appeared first on Power Engineering International.

Read more at Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here